ask="6.31"
ask_size="3000"
average_daily_volume="1461310"
bid="6.23"
bid_size="700"
book_value="0.21"
change="-0.17"
change_from_200_day_moving_average="0.74"
change_from_50_day_moving_average="0.31"
change_from_52_week_high="-1.57"
change_From_52_week_low="3.43"
change_in_percent="-2.66%"
close="6.23"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.56"
ebitda="-113.37M"
eps_estimate_current_year="-1.42"
eps_estimate_next_quarter="-0.19"
eps_estimate_next_year="-0.59"
ex_dividend_date="N/A"
float_shares="71327000"
high="6.43"
high_52_weeks="7.80"
last_trade_date="1/12/2017"
last_trade_price="6.23"
last_trade_size="976"
last_trade_time="3:59pm"
low="6.10"
low_52_weeks="2.80"
market_capitalization="660.13M"
moving_average_200_day="5.49"
moving_average_50_day="5.92"
name="Keryx Biopharmaceuticals
Inc."
notes="N/A"
one_year_target_price="7.21"
open="6.41"
pe_ratio="N/A"
peg_ratio="-0.04"
percent_change_from_200_day_moving_average="+13.46%"
percent_change_from_50_day_moving_average="+5.27%"
percent_change_from_52_week_high="-20.13%"
percent_change_from_52_week_low="+122.50%"
previous_close="6.40"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="30.77"
price_per_sales="24.02"
revenue="28.23M"
shares_outstanding="105960000"
short_ratio="14.92"
stock_exchange="NCM"
symbol="KERX"
volume="1970133"
weeks_range_52="2.80 - 7.80"
